C-RAD announced today orders from Varian Medical Systems to equip Nya Karolinska Solna (NKS), Sweden with its latest SIGRT (Surface Image Guided Radiation Therapy) solution.
The contract includes the supply of C-RAD’s cutting edge surface tracking solution based on the products Sentinel 4DCT and Catalyst HD. It includes also products that C-RAD is distributing for other vendors in the field of radiation therapy in Sweden. The order has a value of approximately 22.7 MSEK.
In August 2017, C-RAD announced a contract with Elekta Instrument to supply radiation therapy equipment to NKS and Södersjukhuset. This agreement is being amended. As the present order with Varian is overlapping with the agreement with Elekta that was announced in August, C-RAD is booking the difference of 6,7 MSEK as additional order intake in Q1 2018.
Approximately forty percent of the order volume is allocated to distribution products and sixty percent to C-RAD products. For the C-RAD products, the gross profit margin is higher than on sales of distribution products. It is expected to commence delivery and installation in April 2018 and finalize implementation until the end of 2018.
The systems will be delivered with the complete C-RAD software suite with modules for patient positioning, respiratory gating and motion monitoring during treatment to ensure exceptionally high precision and efficiency. C-RAD provides interfaces to seamlessly integrate its products into the workflow, for a maximum in user comfort and optimized patient safety.
Nya Karolinska Solna is the project name for the state-of-the-art hospital currently under construction next to Karolinska University Hospital in Solna close to Stockholm, Sweden. It is expected to be fully operational in 2018. NKS is being built to be able to meet the demands of the future in relation to health and medical care – with a greater focus on the patient's needs, faster provision of care, and increased patient safety with single rooms for all inpatients.
“We are very much looking forward to continue to collaborate with the team of NKS and Södersjukhuset. NKS confirmed their strong interest to equip their state of the art university hospital with the C-RAD solution”, says Tim Thurn, CEO and President of C-RAD AB, “At Södersjukhuset the first systems have been installed and clinically implemented. C-RAD is very proud to contribute to improve cancer care in the Stockholm region.”
About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WFOE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com
This information is information that C-RAD AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 16:30 CEST on April 4, 2018.
